{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:19:11Z","timestamp":1778174351203,"version":"3.51.4"},"reference-count":98,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.1080\/1744666x.2021.1886079","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T02:44:29Z","timestamp":1614566669000},"page":"255-268","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy"],"prefix":"10.1080","volume":"17","author":[{"given":"Linda","family":"Cox","sequence":"first","affiliation":[{"name":"Associate Professor of Medicine Nova Southeastern University","place":["Ft. Lauderdale, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,2,28]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"Pawankar R Canonica W Holgate S et al. The WAO White Book on Allergy https:\/\/www.worldallergy.org\/UserFiles\/file\/WAO-White-Book-on-Allergy_web.pdf accessed on 6\/4\/20. 2013."},{"key":"e_1_3_5_4_1","unstructured":"EAACI. Tracking the allergy crisis in europe http:\/\/www.eaaci.org\/documents\/EAACI_Advocacy_Manifesto.pdf accessed on 6\/4\/20. 2016."},{"key":"e_1_3_5_5_1","unstructured":"CDC ASthma Facts https:\/\/www.cdc.gov\/asthma\/pdfs\/asthma_facts_program_grantees.pdf accessed on 6\/4\/20. 2013."},{"key":"e_1_3_5_6_1","unstructured":"Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care 2017 Jun;23(8 Suppl):S115\u2013S123."},{"key":"e_1_3_5_7_1","doi-asserted-by":"crossref","unstructured":"Zhang Y Zhang L. Increasing prevalence of allergic rhinitis in china. Allergy Asthma Immunol Res 2019 Mar;11(2):156\u2013169.","DOI":"10.4168\/aair.2019.11.2.156"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2009.01057.x"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.04.036"},{"issue":"7","key":"e_1_3_5_10_1","first-page":"CD001563","article-title":"House dust mite avoidance measures for perennial allergic rhinitis","volume":"2010","author":"Sheikh A","unstructured":"Sheikh A, Hurwitz B, Nurmatov U, et al. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Re. 2010(7):CD001563","journal-title":"Cochrane Database Syst Re"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2012.02.015"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-015-0055-x"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.12.973"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.08.030"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta17270"},{"issue":"4","key":"e_1_3_5_16_1","first-page":"27","article-title":"Economic aspects of sublingual immunotherapy [Review]","volume":"22","author":"Incorvaia C","year":"2009","unstructured":"Incorvaia C, Ariano R, Berto P, et al. Economic aspects of sublingual immunotherapy [Review]. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4 Suppl):27\u201330.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60190-1"},{"key":"e_1_3_5_18_1","doi-asserted-by":"crossref","unstructured":"Br\u00fcggenj\u00fcrgen B Reinhold T. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria Spain and Switzerland. J Med Econ. 2018 Apr;21(4):374\u2013381.","DOI":"10.1080\/13696998.2017.1419959"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S44079"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.22034"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2012.03.001"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00013904"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01367.x"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990902915061"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.05.012"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60475-9"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2010.31.3329"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.05.013"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.02.007"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap2008.29.3072"},{"issue":"4","key":"e_1_3_5_31_1","first-page":"297","article-title":"Congestion and sleep impairment in allergic rhinitis","volume":"29","author":"Sardana N","year":"2011","unstructured":"Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol. 2011 Dec;29(4):297\u2013306.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2009.30.3230"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2294VV"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01620.x"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.07.025"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.07.020"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.014"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01451.x"},{"key":"e_1_3_5_39_1","unstructured":"deShazo R Kemp S Allergic rhinitis: clinical manifestations epidemiology and diagnosis https:\/\/www-uptodate-com.ezproxylocal.library.nova.edu\/contents\/allergic-rhinitis-clinical-manifestations-epidemiology-and-diagnosis?search=allergic%20rhinitis&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2 accessed 6\/10\/20. UpToDate. 2020."},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000150"},{"issue":"10","key":"e_1_3_5_41_1","first-page":"517","article-title":"[Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study]","volume":"106","author":"Marcellusi A","year":"2015","unstructured":"Marcellusi A, Viti R, Incorvaia C, et al. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study]. Recenti Prog Med. 2015 Oct;106(10):517\u2013527.","journal-title":"Recenti Prog Med"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01548.x"},{"key":"e_1_3_5_43_1","volume-title":"Panel survey. Statistical brief #204: allergic rhinitis: trends in use and expenditures, 2000 and 2005. May 2008","author":"Medical Expenditure SA","year":"2008","unstructured":"Medical Expenditure SA. Panel survey. Statistical brief #204: allergic rhinitis: trends in use and expenditures, 2000 and 2005. May 2008. Bethesda, MD: Agency for Healthcare Research and Quality; 2008. [accessed 5\/26\/2015]. meps.ahrq.gov\/mepsweb\/data_files\/publications\/st204\/stat204.pdf."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200927050-00002"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125003053"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.09.002"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X112552"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-2-20"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta19140"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02706.x"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13254"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000084"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12112"},{"issue":"2","key":"e_1_3_5_54_1","first-page":"159","article-title":"Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma","volume":"27","author":"Ariano R","year":"2006","unstructured":"Ariano R, Berto P, Tracci D, et al. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy and Asthma Proceedings. 2006 Mar-Apr;27(2):159\u2013163.","journal-title":"Allergy and Asthma Proceedings"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60498-X"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X187865"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0546(05)73246-8"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200017010-00003"},{"issue":"8","key":"e_1_3_5_59_1","first-page":"303","article-title":"Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma","volume":"37","author":"Berto P","year":"2005","unstructured":"Berto P, Bassi M, Incorvaia C, et al. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma. Allerg Immunol (Paris). 2005 Oct;37(8):303\u2013308.","journal-title":"Allerg Immunol (Paris)"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696990701438587"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.05.003"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01743.x"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61090-3"},{"issue":"5","key":"e_1_3_5_64_1","first-page":"148","article-title":"Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in france","volume":"39","author":"Omnes LF","year":"2007","unstructured":"Omnes LF, Bousquet J, Scheinmann P, et al. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in france. Eur Ann Allergy Clin Immunol. 2007 May;39(5):148\u2013156.","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"e_1_3_5_65_1","unstructured":"Claes C Mittendorf T. von der Schulenburg JM. Health economic modeling of allergen-specific immunotherapy in seasonal allergic rhinitis from a health care payer\u2019s perspective [H.] Allergo J. 2009;18:60\u201370."},{"key":"e_1_3_5_66_1","first-page":"168","volume-title":"Encyclopedia of public health","author":"Cost-Consequence Analysis","year":"2008","unstructured":"Cost-Consequence Analysis. Encyclopedia of public health. editor, Kirch W. Springer Netherlands: Dordrecht; 2008. p.168."},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta24180"},{"key":"e_1_3_5_68_1","unstructured":"Cost-effectiveness analysis https:\/\/www.cdc.gov\/policy\/polaris\/economics\/cost-effectiveness.html accessed 6\/15\/20."},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802103-3.00034-1"},{"key":"e_1_3_5_70_1","unstructured":"Cost-benefit analysis https:\/\/www.cdc.gov\/policy\/polaris\/economics\/cost-benefit-analysis.html accessed 6\/14\/20."},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0067-z"},{"issue":"3","key":"e_1_3_5_72_1","first-page":"138","article-title":"[Economic evaluation of a tablet-based vaccination against hay fever in Denmark]","volume":"170","author":"Poulsen PB","year":"2008","unstructured":"Poulsen PB, Pedersen KM, Christensen J, et al. [Economic evaluation of a tablet-based vaccination against hay fever in Denmark]. Ugeskr Laeger. 2008 Jan 14;170(3):138\u2013142.","journal-title":"Ugeskr Laeger"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-3-30"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-015-0045-z"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.688904"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602223340804"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.026"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2009.11.010"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.5414\/ALX01507"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253726"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01549.x"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21061"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S34832"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232753"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14246"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300409"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.662"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.662"},{"key":"e_1_3_5_89_1","unstructured":"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-treatment-peanut-allergy-children accessed 5\/28\/20."},{"key":"e_1_3_5_90_1","unstructured":"Dearment A FDA cancels adCom meeting for dBV\u2019s peanut allergy patch citing efficacy concerns https:\/\/medcitynews.com\/2020\/03\/fda-cancels-adcom-meeting-for-dbvs-peanut-allergy-patch-citing-efficacy-concerns\/ accessed 5\/28\/20. MedCityNews. 2020."},{"key":"e_1_3_5_91_1","doi-asserted-by":"crossref","unstructured":"Shaker M Greenhawt M. Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis. JAMA Netw Open. 2019 May 3;2(5):e193242..","DOI":"10.1001\/jamanetworkopen.2019.3242"},{"key":"e_1_3_5_92_1","unstructured":"Esch RE. Specific immunotherapy in the U.S.A.: general concept and recent initiatives. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M.2003 (94):17-22; discussion 23."},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.21040"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12373"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02759.x"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6771.265"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.01.010"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.035"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410702"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-015-0057-8"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2021.1886079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:23:46Z","timestamp":1772774626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2021.1886079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,4]]}},"alternative-id":["10.1080\/1744666X.2021.1886079"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2021.1886079","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}